Identity on this record
Chemical name: Melanotan II (MT-II).
Common synonyms: MT2, MT-II, cyclic α-MSH analogue.
CAS number: 121062-08-6 (registry entry).
Structural class: Cyclic heptapeptide α-MSH analogue.
Appearance: Off-white lyophilised powder.
Catalog strength: 10 mg vial.
Those identifiers describe MT-2 as a substance. They do not describe a particular vial. The vial is identified by the name, the nominal fill, and the lot number on its label, checked against the published certificate.
What the catalogue actually sells
MT2 (Melanotan-2) 10mg is the 10 mg lyophilized unit, listed at AED 299 before VAT. The product record stores that sealed unit at 2–8 °C.
Prices are merchandise prices in AED, exclusive of VAT. VAT is added at checkout. A price on this summary is the figure on the product record for MT-2, not a delivered-cost quote. Ordering context that already exists for this compound: Melanotan II research guide.
Lots and certificates
Lot VL-MT2-20260322 is the catalogue certificate for MT2 (Melanotan-2) 10mg. Read it on MT2 (Melanotan-2) 10mg certificate and match the vial in batch verification. A certificate for a different strength, or for a blend that merely contains the same name, does not release this unit.
How the compound record describes the literature
Emerges from University of Arizona melanotan research programs in the 1990s. VaultLabs supplies strictly for qualified in vitro research.
Topics named on the MT-2 record, as literature context rather than as outcomes VaultLabs claims: MC1R/MC4R binding assays; Melanogenesis cell models; Receptor selectivity profiling.
That is context for identifying MT-2. It is not a claim that a vial produces a result in a person, an animal, or a study VaultLabs has not published. VaultLabs does not provide dosage, administration, study-design, or medical guidance.
Points the monograph already states
Points already written on the MT-2 monograph, so a reader can check them against that page:
A cyclic α-MSH analogue with CAS registry number 121062-08-6.
Non-selective across the melanocortin receptor family, in contrast to analogues developed for receptor selectivity.
PT-141 (bremelanotide) is a metabolite of melanotan II, which is why the two appear together in the literature.
Not approved as a medicine in any jurisdiction; several regulators have warned consumers about unlicensed injectable products sold under this name.
Supplied strictly as an in vitro research reference material with lot-linked HPLC certification.
Dispatch and the research-use boundary
VaultLabs dispatches MT-2 from Dubai. Orders leave fulfillment within 24 hours, 7 days a week. Standard delivery is AED 35 to every emirate, and delivery is free when the post-discount merchandise subtotal is AED 500 or more. Checkout shows the fee for the address entered. All VaultLabs products are supplied strictly for laboratory and research use only. They are not intended for human consumption, medical use, personal use, or diagnostic use. VaultLabs does not provide dosage, administration, study-design, or medical guidance.
The full narrative record is the MT-2 compound monograph. Handling of the sealed unit is the MT-2 storage guide. Questions are collected on the MT-2 FAQ. How it differs from neighbouring records is the MT-2 comparison.